Evidence map›Paper›PMID 19412180›Full record

ArticleNature immunology2009

Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappaB signals.

Emmanuel Derudder, Emily J Cadera, J Christoph Vahl, Jing Wang, Casey J Fox, Shan Zha, Geert van Loo, Manolis Pasparakis, Mark S Schlissel, Marc Schmidt-Supprian and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. NF-κB in inflammation and cancer.Cellular & molecular immunology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Nemo-Dependent, ATM-Mediated Signals from RAG DNA Breaks atJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  16. Review
  17. Review
  18. Review
  19. PTIP chromatin regulator controls development and activation of B cell subsets to license humoral immunity in mice.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Emmanuel DerudderImmune Disease Institute, Boston, Massachusetts, USA. derudder@idi.harvard.edu
Emily J Cadera
J Christoph Vahl
Jing Wang
Casey J Fox
Shan Zha
Geert van Loo
Manolis Pasparakis
Mark S Schlissel
Marc Schmidt-Supprian
Klaus Rajewsky
Max Planck Institute of Biochemistry · DEUniversity of California, Berkeley · USGhent University · BEHarvard Global Health Institute · USHarvard University · USJackson Laboratory · USUniversity of Cologne · DE

Funding

BCR signaling during B cell development and maintenanceR37AI054636 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI CARROLL, MICHAEL CRAIG · 2003 to 2012
$5.7M
IKK Signals in Lymphocyte Physiology and PathologyR01AI057947 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI RAJEWSKY, KLAUS · 2004 to 2008
$2.3M
NIAID NIH HHS R01 AI057947NIAID NIH HHS R37 AI054636
6 · The paper itself

Abstract

By genetically ablating IkappaB kinase (IKK)-mediated activation of the transcription factor NF-kappaB in the B cell lineage and by analyzing a mouse mutant in which immunoglobulin lambda-chain-positive B cells are generated in the absence of rearrangements in the locus encoding immunoglobulin kappa-chain, we define here two distinct, consecutive phases of early B cell development that differ in their dependence on IKK-mediated NF-kappaB signaling. During the first phase, in which NF-kappaB signaling is dispensable, predominantly kappa-chain-positive B cells are generated, which undergo efficient receptor editing. In the second phase, predominantly lambda-chain-positive B cells are generated whose development is ontogenetically timed to occur after rearrangements of the locus encoding kappa-chain. This second phase of development is dependent on NF-kappaB signals, which can be substituted by transgenic expression of the prosurvival factor Bcl-2.

Indexed as

AnimalsB-LymphocytesCell DifferentiationI-kappa B KinaseImmunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsIntracellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicNF-kappa BProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Signal TransductionBcl2 protein, mouseI-kappa B KinaseImmunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsIntracellular Signaling Peptides and ProteinsNEMO protein, mouseNF-kappa BProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID19412180
PMCPMC2742984
OpenAlexW2144174797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.